0001104659-21-086990.txt : 20210629
0001104659-21-086990.hdr.sgml : 20210629
20210629191120
ACCESSION NUMBER: 0001104659-21-086990
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210625
FILED AS OF DATE: 20210629
DATE AS OF CHANGE: 20210629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRINT PAUL C
CENTRAL INDEX KEY: 0001236548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39676
FILM NUMBER: 211059682
MAIL ADDRESS:
STREET 1: 7757 DOUGHILL COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92127
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001750149
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
BUSINESS PHONE: 678-392-3419
MAIL ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
4
1
tm2120992d3_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-06-25
0
0001750149
Inhibikase Therapeutics, Inc.
IKT
0001236548
GRINT PAUL C
3350 RIVERWOOD PARKWAY SE, SUITE 1900
ATLANTA
GA
30339
1
0
0
0
Stock Option (right to buy)
2.92
2021-06-25
4
A
0
22677
0
A
2022-06-25
2028-06-25
Common Stock
22677
22677
D
/s/ Milton H. Werner, attorney-in-fact
2021-06-29